Arkolith/Insider Trading/EWTX/Form 4

Russell Alan J

Chief Scientific Officer, DirectorEdgewise Therapeutics, Inc. (EWTX) · full profile →Form 4 · filed Nov 13, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.1M
Net Open-Market Flow
-$2.1M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 12, 2025Sell(S)100K$21.12$2.1M23K
Nov 12, 2025Option exercise(M)100K$0.18$18K123K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 12, 2025Option exercise(M)100K—$01.1M

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001853529-25-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML